Origin Agritech has appointed Dr. Jian Zhang as an independent director and reappointed Dr. Zheng James Chen as Chief Financial Officer, effective March 20, 2026. Dr. Zhang brings over 20 years of global crop biotech expertise, enhancing Origin's R&D and commercialization capabilities. Dr. Chen returns with extensive financial leadership experience, including prior roles as CFO and CEO at Origin, to guide the company through its next growth phase. These leadership changes aim to strengthen Origin's position in agricultural biotechnology and capital markets as it advances its seed technology pipeline.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
